Inclusion Criteria:~* AD according to the National Institute on Aging-Alzheimer's Association criteria.~* MMSE
score between 12 and 24.~* Saliva rinse sample positive for P. gingivalis.~* Plasma pTau217 above cutoff.~*
Subject and caregiver have provided full written informed consent.~* Background symptomatic therapy with
acetylcholinesterase inhibitors, and/or memantine, are allowed if the dose has been stable for 90 days and no
changes are planned during the study.~* Modified Hachinski score â‰¤4 at screening.~
